A detailed history of Lionshead Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lionshead Wealth Management, LLC holds 934 shares of LLY stock, worth $954,267. This represents 0.57% of its overall portfolio holdings.

Number of Shares
934
Previous 543 72.01%
Holding current value
$954,267
Previous $448 Million 58.91%
% of portfolio
0.57%
Previous 0.47%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 10, 2025

BUY
$625.65 - $812.69 $244,629 - $317,761
391 Added 72.01%
934 $713 Million
Q1 2025

May 14, 2025

SELL
$725.72 - $929.72 $31,931 - $40,907
-44 Reduced 7.5%
543 $448 Million
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $426,866 - $547,119
587 New
587 $453 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lionshead Wealth Management, LLC Portfolio

Follow Lionshead Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lionshead Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lionshead Wealth Management, LLC with notifications on news.